Improving clinical outcomes for hospital patients initiated on warfarin

Journal of Pharmacy Practice and Research

Volumn 37, Issue 4, 2007, Pages 295-302

  Bereznicki, Luke R ^a   Jackson, Shane L ^a   Morgan, Steven M ^a   Boland, Camille ^b   Marsden, Katherine A ^b   Jupe, David M ^b   Vial, Janet H ^a   Peterson, Gregory M ^a  

^a UNIVERSITY OF TASMANIA   (Australia)

^b ROYAL HOBART HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

WARFARIN;

ADOLESCENT; ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; BLEEDING; CONFIDENCE INTERVAL; CONTROLLED STUDY; DRUG QUALITY; FEMALE; FOLLOW UP; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PATIENT COMPLIANCE; RISK; THROMBOEMBOLISM; TREATMENT OUTCOME;

EID: 39449098451     PISSN: 1445937X     EISSN: None     Source Type: Journal    
DOI: 10.1002/j.2055-2335.2007.tb00769.x     Document Type: Article

References (22)

1. Hirsh J, Fuster V, Ansell J, Halperin JL. American Heart Association/American College of Cardiology Foundation guide to warfarin therapy. Circulation 2003; 107: 1692-711.
2. Levine MN, Raskob G, Landefeld S, Kearon C. Hemorrhagic complications of anticoagulant treatment. Chest 2001; 119: 108S-121S.
3. Palareti G, Leali N, Coccheri S, Poggi M, Manotti C, Dangelo A, et al. Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT). Lancet 1996; 348: 423-8.
4. Pengo V, Zasso A, Barbero F, Biasiolo A, Rampazzo P, Brocco T. Initiation of warfarin treatment in outpatients with nonrheumatic atrial fibrillation. A scheme for early indication of maintenance dose. Clin App Thromb Hemost 1998; 4: 274-6.
5. Jackson SL, Peterson GM, Vial JH, Jupe DM. Improving the outcomes of anticoagulation: An evaluation of home follow-up of warfarin initiation. J Intern Med 2004; 256: 137-44.
6. Fennerty A, Dolben J, Thomas P, Backhouse G, Bentley DP, Campbell IA, et al. Flexible induction dose regimen for warfarin and prediction of maintenance dose. BMJ 1984; 288: 1268-70.
7. Harrison L, Johnston M, Massicotte MP, Crowther M, Moffat K, Hirsh J. Comparison of 5-mg and 10-mg loading doses in initiation of warfarin therapy. Ann Intern Med 1997; 126: 133-6.
8. Roberts GW, Druskeit T, Jorgensen LE, Wing LM, Gallus AS, Miller C, et al. Comparison of an age adjusted warfarin loading protocol with empirical dosing and Fennerty's protocol. Aust N Z J Med 1999; 29: 731-6.
9. Gedge J, Orme S, Hampton KK, Channer KS, Hendra TJ. A comparison of a low-dose warfarin induction regimen with the modified Fennerty regimen in elderly inpatients. Age Ageing 2000; 29: 31-4.
10. Pengo V, Biasiolo A, Pegoraro C. A simple scheme to initiate oral anticoagulant treatment in outpatients with nonrheumatic atrial fibrillation. Am J Cardiol 2001; 88: 1214-16.
11. Kovacs MJ, Anderson DA, Wells PS. Prospective assessment of a nomogram for the initiation of oral anticoagulation therapy for outpatient treatment of venous thromboembolism. Pathophysiol Haemost Thromb 2002; 32: 131-3.
12. Roberts GW, Helboe T, Nielsen CB, Gallus AS, Jensen I, Cosh DG, et al. Assessment of an age-adjusted warfarin initiation protocol. Ann Pharmacother 2003; 37: 799-803.
13. Garcia D, Regan S, Crowther M, Hughes RA, Hylek EM. Warfarin maintenance dosing patterns in clinical practice: implications for safer anticoagulation in the elderly population. Chest 2005; 127: 2049-56.
14. Bereznicki LR, Jackson SL, Morgan S, Peterson GM, Vial JH, Jupe D, et al. A review of the initiation of anticoagulation: does lack of adherence to guidelines result in an increased risk of adverse outcomes? [poster]. Advancing Haematology Through Science: The Annual Scientific Meeting of the Australasian Society of Thrombosis and Haemostasis; 2004; Melbourne, Australia; 2004.
15. Davis DA, Thomson MA, Oxman AD, Haynes RB. Changing physician performance. A systematic review of the effect of continuing medical education strategies. JAMA 1995; 274: 700-5.
16. Jackson SL, Peterson GM, Bereznicki LR, Misan GM, Jupe DM, Vial JH. Improving the outcomes of anticoagulation in rural Australia: an evaluation of pharmacist-assisted monitoring of warfarin therapy. J Clin Pharm Ther 2005; 30: 345-53.
17. Ansell J, Hirsh J, Poller L, Bussey H, Jacobson A, Hylek E. The pharmacology and management of the vitamin K antagonists: The seventh ACCP conference on antithrombotic and thrombolytic therapy. Chest 2004; 126: 204S-233S.
18. Siguret V, Gouin I, Debray M, Perret-Guillaume C, Boddaert J, Mahe I, et al. Initiation of warfarin therapy in elderly medical inpatients: A safe and accurate regimen. Am J Med 2005; 118: 137-42.
19. Corbett NE, Peterson GM. Review of the initiation of anticoagulant- therapy. J Clin Pharm Ther 1995; 20: 221-4.
20. Bates DW, Cullen DJ, Laird N, Petersen LA, Small SD, Servi D, et al. Incidence of adverse drug events and potential adverse drug events. Implications for prevention. ADE Prevention Study Group. JAMA 1995; 274: 29-34.
21. Senst BL, Achusim LE, Genest RP, Cosentino LA, Ford CC, Little JA, et al. Practical approach to determining costs and frequency of adverse drug events in a health care network. Am J Health Syst Pharm 2001; 58: 1126-32.
22. Burgess CL, Holman CD, Satti AG. Adverse drug reactions in older Australians, 1981-2002. Med J Aust 2005; 182: 267-70.